Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Bricanyl (Terbutaline sulphate) - Important Safety Information from AstraZeneca as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
23/10/2002
Problem Or Issue:
Important Safety Information communication from AstraZeneca on important restrictions regarding the use of short-acting beta agonists (SABAs) in obstetric indications.
Important Safety Information - Bricanyl (Terbutaline sulphate)
« Back
Date Printed: 24/04/2024